PLUS1
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.08 | 1.1% | 7.38 | 7.38 | 7.30 | 7.35 | 7.30 | 09:40:49 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 7.35 | 7.41 | 0.06 | 0.81% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 37 | 6,389 | $ 7.33 | $ 46,843 | 966,183 | 4.47 - 16.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:41:03 | 5 | $ 7.35 | USD |
Protagonist Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 200.78M | 27.21M | $ -38.92M | -1.74 | - | 26.67M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Protagonist Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/07/2020 | 07:00 | PR Newswire (US) | Protagonist Therapeutics Achieves Milestone in Janssen.. |
| 1/06/2020 | 07:00 | PR Newswire (US) | Protagonist Therapeutics Initiates Phase 2 Study of Novel.. |
| 12/16/2019 | 11:07 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) |
| 12/03/2019 | 18:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/03/2019 | 18:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/03/2019 | 18:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 12/03/2019 | 18:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.71 | 7.46 | 6.64 | 7.16 | 199,946 | 0.67 | 9.99% |
| 1 Month | 7.22 | 7.60 | 6.52 | 7.00 | 231,978 | 0.16 | 2.22% |
| 3 Months | 12.17 | 13.77 | 4.47 | 7.89 | 730,498 | -4.79 | -39.36% |
| 6 Months | 13.08 | 16.67 | 4.47 | 9.00 | 430,167 | -5.70 | -43.58% |
| 1 Year | 8.04 | 16.67 | 4.47 | 9.73 | 317,912 | -0.66 | -8.21% |
| 3 Years | 17.73 | 23.97 | 4.47 | 10.45 | 204,843 | -10.35 | -58.38% |
| 5 Years | 12.00 | 26.3598 | 4.47 | 10.82 | 189,004 | -4.62 | -38.5% |
Protagonist Therapeutics Description
| Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. |
